Lung transplant and cystic fibrosis: what's new from the UK and France?

Noone, Peadar G.
August 2008
Thorax;Aug2008, Vol. 63 Issue 8, p668
Academic Journal
The article discusses a study which suggests that lung transplant for most children with cystic fibrosis under 18 years of age offers no survival advantage. The complex statistical methodology and conclusions have since been challenged and rebutted by several lung transplant experts. It discusses the controversies with regards to lung transplant for patients with cystic fibrosis infected with Burkholderia cepacia complex microorganism.


Related Articles

  • Quality of life in patients with cystic fibrosis depending on the severity of the disease and method of its treatment. Dębska, Grażyna; Cepuch, Grażyna; Mazurek, Henryk // Advances in Hygiene & Experimental Medicine / Postepy Higieny i ;2014, Vol. 68, p498 

    Quality of life is a measure not only of disease severity and its functional impact (physical, psychological, and social functioning) but also the efficacy of novel therapies. The aim of this study was to analyze the quality of life in cystic fibrosis patients depending on the severity of the...

  • CYSTIC FIBROSIS.  // Current Medical Literature: Respiratory Medicine;2005, Vol. 19 Issue 3, p58 

    Presents citations and clinicians' notes on cystic fibrosis. "Weight and Energy: Parents' and Children's Perspectives on Managing Cystic Fibrosis Diet," by E. Savage and P. Callery; "Lung Function in Adults With Cystic Fibrosis at Altitude: Impact on Air Travel," by R. Fischer, S. M. Lang, K....

  • Outcome of critically ill lung transplant candidates on invasive respiratory support. Gottlieb, Jens; Warnecke, Gregor; Hadem, Johannes; Dierich, Martin; Wiesner, Olaf; Fühner, Thomas; Strueber, Martin; Haverich, Axel; Welte, Tobias // Intensive Care Medicine;Jun2012, Vol. 38 Issue 6, p968 

    Purpose: Lung transplantation (LTx) of patients on mechanical ventilation (MV) or extracorporeal support (ECS) is controversial because of impaired survival. Prognostic factors to predict survival should be identified. Methods: A retrospective analysis was performed in a single centre of all...

  • End-of-Life Care in Adults with Cystic Fibrosis. Philip, Jennifer A.M.; Gold, Michelle; Sutherland, Sharon; Finlayson, Felicity; Ware, Claire; Braithwaite, Maxine; Harris, Jane; Kotsimbos, Tom; Wilson, John F. // Journal of Palliative Medicine;Mar2008, Vol. 11 Issue 2, p198 

    Background: Cystic fibrosis (CF) is a life-limiting congenital disease, with most patients dying at a young age of progressive lung disease. Lung transplantation offers hope for many but may not occur. There is little to guide the provision of palliative care to this young population who...

  • Some stories are heartbreaking, some are heartwarming; this one is both. S. E. H. // British Columbia Medical Journal;Nov2013, Vol. 55 Issue 9, p409 

    The article highlights the case of a woman who was diagnosed with cystic fibrosis at 14 years old. While she was chronically ill the most of her childhood, she was determined to beat the odds and went on to become a teacher. At 21 years old, she was diagnosed with diabetes and underwent double...

  • Lung transplantation for Cystic fibrosis: satisfactory results in specialized centres. Bonnette, Pierre // European Journal of Cardio-Thoracic Surgery;Feb2012, Vol. 41 Issue 2, p440 

    The author presents his views on the development in lung transplantation technique for the treatment of cystic fibrosis (CF), a formidable genetic disease. He discusses the recent modifications which include grafting with extended donor criteria and evaluating grafts with ex vivo reperfusion...

  • Challenges in pulmonary fibrosis: 8 The need for an international registry for idiopathic pulmonary fibrosis. Wilson, J. W.; du Bois, R. M.; King Jr., T. E. // Thorax;Mar2008, Vol. 63 Issue 3, p285 

    Improved survival from idiopathic pulmonary fibrosis (IPF) is dependent on better understanding of the epidemiology of the disease, its diagnostic spectrum in global terms and an analysis of outcomes from emerging therapies at a significant level. Outside major lung transplant centres, few...

  • A RESEARCHER'S PERSPECTIVE. Lowton, Karen // BMJ: British Medical Journal (International Edition);6/16/2007, Vol. 334 Issue 7606, p1271 

    The article presents the author's perspective on cystic fibrosis and the advances that have been made in its treatment. Arguments are presented which suggest that better understanding of the condition has ensured progressively more effective treatment and care. A discussion of an increase in the...

  • A disease called 'sixty-five roses'.  // Nature Structural Biology;Dec2002, Vol. 9 Issue 12, p887 

    Provides information on cystic fibrosis (CF). Cause of CF; Increase in efforts to educate the public about preventing CF; Initial screen for CF.


Read the Article


Sign out of this library

Other Topics